1 August 2019

Grint, D, McDonald, H, Walker, J, Amirthalingam, G, Andrews, N and Thomas, SL (2019). Post-Vaccine Zoster Disease - ICD-10 Codes. [Data Collection]. London School of Hygiene & Tropical Medicine, London, United Kingdom. https://doi.org/10.17037/DATA.00001339.

Grint, D, McDonald, H, Walker, J, Amirthalingam, G, Andrews, N and Thomas, SL (2019). Post-Vaccine Zoster Disease - Read Codes. [Data Collection]. London School of Hygiene & Tropical Medicine, London, United Kingdom. https://doi.org/10.17037/DATA.00001338.

15 August 2019

Grint, D, McDonald, H, Walker, J, Amirthalingam, G, Andrews, N and Thomas, SL (2019). Code lists for "Inadvertent administration of live zoster vaccine to immunosuppressed individuals; vaccine-related disease is a rare occurrence". [Project]. London School of Hygiene & Tropical Medicine, London, United Kingdom. https://doi.org/10.17037/DATA.00001336.

10 December 2019

Der, J, Grint, D, Narh, CT, Bonsu, F and Grant, AD (2019). Data for "Where are patients missed in the tuberculosis diagnostic cascade? A prospective cohort study in Ghana". [Data Collection]. London School of Hygiene & Tropical Medicine, London, United Kingdom. https://doi.org/10.17037/DATA.00001529.

17 August 2020

Walker, J, Grint, D, Strongman, H, Eggo, RM, Peppa, M, Minassian, C, Mansfield, KE, Rentsch, C, Douglas, IJ, Mathur, R, Wong, A, Quint, JK, Andrews, N, Lopez-bernal, J, Scott, A, Ramsay, M, Smeeth, L and McDonald, H (2020). UK prevalence of risk factors for severe COVID-19 disease, by age and region: point prevalence estimates in 2019 and 2014, using electronic health records. [Data Collection]. London School of Hygiene & Tropical Medicine, London, United Kingdom. https://doi.org/10.17037/DATA.00001833.

13 January 2025

Tumusiime, V, Ruzagira, E, Norcross, C, Eshun-Wilsonova, I, Kitonsa, J, Bahemuka, UM, Grint, D, Kimbugwe, G, Kakande, A, Lawrence, DS, Mwendia, F, Van Solinge, R, Van Eygen, V, Boateng, FA and Cresswell, F (2025). SPIRIT Checklist for: Efficacy and safety of long acting injectable cabotegravir and rilpivirine in improving HIV-1 control in Sub Saharan Africa: Protocol for a phase 3b open label randomized controlled trial (IMPALA). [Data Collection]. London School of Hygiene & Tropical Medicine, London, United Kingdom. https://doi.org/10.17037/DATA.00004492.